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Vascular access for hemodialysis in the elderly
Nicola Swindlehurst, MBBS, Andrew Swindlehurst, MBBS, Heather Lumgair, MBBS,
Irene Rebollo Mesa, PhD, Nizam Mamode, MB, FRCS, Roberto Cacciola, MBBS, MD, FRCS,
and Iain Macdougall, MBChB, MD, FRCP, London, United Kingdom
Objective: The number of elderly patients needing hemodialysis is constantly increasing year by year. Elderly patients with
end-stage renal failure represent a challenge for the surgeons who create vascular accesses. The aim of this study was to
analyze the outcome of conduit creation in the elderly in our institution and to compare it with the outcome of a cohort
of patients aged <65 years.
Methods: The study was performed retrospectively on prospectively collected data. The study period was between January
1, 2000, and December 31, 2006. We identified first attempts at conduit creations, including arteriovenous fistulas
(AVFs) and grafts, in elderly patients (aged >65 years) who were allocated to group A, and in nonelderly patients (<65
years) who were allocated to group B. Subsequent attempts at conduit creations in the same patient were omitted from
the data set.
Results: There were 246 first AVFs in group A and 89 in group B. At a mean follow-up of 25.46 months (SD, 18.93
months), the primary patency (PP) rate of all AVFs was 70% in group A and 68% in group B (P  .75). The assisted PP
rate was 73% in group A and 77% in group B (P  .4). The secondary patency (SP) rate was 73% in group A and 79% in
group B (P  .9). Also, the differences in the 12-month cumulative patency rates (including PP, assisted PP, and SP) in
the two groups (65% vs 60%) were not significant. At a mean follow-up of 25 months, death with a functioning conduit
occurred at the same rate in both groups (56% and 54%), and mean conduit survival did not differ according to age (516
and 511 days). The incidence of failure to mature was higher in group A (6.1% vs 1.1%, P  .03). Patency rates for
different types of conduits were similar between the two groups, although polytetrafluoroethylene grafts had a higher
cumulative patency in group A (94% vs 69%; P  .05). The rate of procedures to salvage conduits was 2.5% in group A
vs 10.1% in group B. Mean hospital stay for group A and group B was 3.2 days.
Conclusions: In our experience, the creation of permanent hemodialysis access in the elderly with AVF is not only possible
but also proved to have a short hospital stay, high patency rates, and an acceptable rate of further intervention. (J Vasc
Surg 2011;53:1039-43.)
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eOver the years, the percentage of elderly patients re-
quiring hemodialysis (HD) has constantly and dramatically
increased. This has been shown in several published series,
and now 50% of all patients starting HD are aged 60
years.1,2 Originally, HD was a type of renal replacement
therapy reserved for younger and fitter individuals. Im-
proved facilities and more tolerable HD regimens have
made it possible for older patients to receive HD.
Elderly patients with end-stage renal failure represent a
particular challenge because of the increased prevalence of
comorbidities, such as diabetes, that may lead to increased
vascular pathology and greater perioperative risk. In addi-
tion, elderly patients are likely to have undergone numer-
ous procedures requiring venipuncture throughout their
lifetime, leading to increased risk of stenosis and subse-
quent failure after arteriovenous fistula (AVF) creation.3-6
Late presentation and subsequent late referral for AVF
creation also contribute to an increased risk of failure in
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doi:10.1016/j.jvs.2010.09.068hese patients. Cofactors associated with the highest risk of
ailure include the combination of nonwhite ethnicity, di-
betes, and female gender.4
A limited body of evidence on the outcome of AVF in
he elderly has been available in the literature; the results are
onflicting, and many series are now dated. There is also
inimal guidance from the National Kidney Foundation
idney Disease Outcomes Quality Initiative and the Euro-
ean vascular access guidelines regarding the elderly and
heir different medical and surgical implications.
The aim of this study was to analyze the outcome of
VF creation in the elderly in our institution and to com-
are it with the outcome of a cohort of patients aged 65
ears.
ETHODS
In this study, we analyzed all conduits constructed for
emodialysis access performed at King’s College Hospital
etween January 1, 2000, and December 31, 2006. First-
ime AVFs and grafts, but not catheter placement, were
ncluded in the study. The analysis was performed retro-
pectively on prospectively collected data.
Before the conduit was created, the patients were as-
essed by the surgeon, and preoperative duplex ultrasound
maging was performed selectively when it was not possible
o identify suitable veins clinically or when the clinical
xamination suggested possible impaired arterial inflow. A
ein was considered suitable for use where duplex imaging
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April 20111040 Swindlehurst et alshowed a consistent diameter of at least 2 mm. Our ap-
proach in the elderly is similar to younger patients: we favor
the creation of distal conduit in the nondominant limb first.
Also, we aim to create the conduit preemptively, so that
when possible the patient will be able to start HD through
an autogenous fistula.
The decision about whether a radiocephalic, brachio-
cephalic, brachiobasilic, or prosthetic access was formed
was taken following the current Vascular Access Society
Guidelines and was based on vein size, the presence of
collaterals, and medical history. Venography was per-
formed when duplex imaging or the clinical examination
suggested the presence of a proximal venous stenosis, and
(rarely) arteriography was performed when a proximal ar-
terial stenosis was suspected.
We identified all patients aged 65 years when their
first conduit was created and allocated them to group A.We
also identified as a comparison group a cohort of patients
aged 65 years and allocated them to group B. Patients
may have received more than one conduit during the study
period, but only the first conduit was considered. The
comparison group included 100 randomly selected conduit
creations in patients aged65 years; the comparison group
then fell to 89 when duplicate conduit attempts on the
same patient were omitted from the data set.
The primary outcome measures were primary patency
(PP), assisted primary patency (APP), and secondary pa-
tency (SP), as defined by Sidawy et al.7 A secondary end
point was the rate of interventions in the two groups,
defined as surgical revision, thrombectomy, and angio-
plasty. Failure to mature means that the conduit is patent,
but the flow is insufficient for adequate dialysis. A conduit
was deemed successful if it was used for dialysis.
Continuous data were analyzed using the t test, and
dichotomous data were analyzed with the 2 test. The
Kaplan-Meier method and log-rank test were used to eval-
uate time-to-event distribution.
RESULTS
There were 246 conduits in group A (65 years) and
89 in group B (65 years). All patient characteristics are
summarized in Table I. Sex distribution was similar in the
two groups. White ethnicity and diabetes were more com-
mon in group A. A higher number of patients in group A
had undergone conduit creation before they needed HD.
The mean follow-up period was 25.46 months (SD, 18.93
months). The anatomic site of the conduits showed statis-
tically nonsignificant differences in the two groups.
There was no difference in hospital stay in the two
groups (Table I).
All primary outcome measures showed no significant
differences in the two groups. At a mean follow-up of 25
months, the PP rate of all conduits was 70% in group A and
68% in group B (P .75). The APP rate was 73% in group
A and 77% in group B (P  .4). The SP rate was 73% in
group A and in 79% group B (P  .9). Similarly, when we
evaluated the 12-month patency rates, there were no sig-
nificant differences in the two groups (Table II). gWe also analyzed the outcome at 12 months of a
ubgroup of 100 patients aged75 years. The PP rate was
7%, the APP rate was 78%, and the SP rate was 79%.
The causes of primary failure showed a similar incidence
f thrombosis and stenosis in the two groups; however,
here was increased failure immediately postoperatively in
roup B (although the numbers were small) and more
ailure to mature in group A (Table III).
A total of 63 procedures were performed to treat pri-
ary failure, defined as loss of PP (32 in group A and 31 in
able I. Patient and conduit characteristics
ariable
Group A
(65)
Group B
(65) P
otal No. 246 89
ge, years
Mean (SD) 74 (5.7) 49 (10.4)
Range 62-89 22-64
ale, No. (%) 153 (62.2) 49 (55) .2
ollow-up, mean (SD) mon 24.59 (17.81) 27.87 (21.65) .16
thnicity, No. (%)
Caucasian 154 (62) 42 (47) .01
Black 53 (21) 32 (36) .007
Asian 19 (7) 5 (6)
Chinese 3 (1) 1 (1)
Unrecorded 17 (7) 9 (10)
iabetes, No. (%) 102 (41) 26 (29) .04
emodialysis, a No. (%) 114 (46) 57 (64) .004
ype of conduit, No. (%)
Radiocephalic 69 (27) 22 (26) .5
Brachiocephalic 142 (58) 42 (47) .08
Brachiobasilic 25 (11) 12 (13) .4
Prostheticb 10 (4) 13 (14) .05
ospital stay, mean days 3.2 3.2
Receiving hemodialysis at time of arteriovenous fistula creation.
Including brachioaxillary and looped forearm access.
able II. Patency rate (%) for all conduits at 12 months
roup
PP APP SP
(%) (%) (%)
roup A (65) 63 65 65
roup B (65) 54 61 61
PP, Assisted primary patency; PP, primary patency; SP, secondary patency.
able III. Causes of primary nonfunction
auses
Group A (65) Group B (65)
PaNo. (%) No. (%)
cclusion/thrombosisb 32 (13) 8 (8.9) .2
tenosis 11 (4.4) 7 (7.8) .2
mmediate failurec 8 (3.2) 10 (11.2) .002
ailed to mature 15 (6.1) 1 (1.1) .03
ther 6 (2.4) 1 (1.1) .4
Values of P  .05 are not significant.
Arteriovenous fistula failed 24 hours of creation.
Arteriovenous fistula failed 24 hours of creation.roup B). Details are summarized in Table IV. Of these, 15
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Volume 53, Number 4 Swindlehurst et al 1041(29%) have been successful. The rate of procedures to
salvage conduits was higher in group B and proved to be
more successful in group B, leading to a higher rate of
10.1% salvaged conduits vs 2.5% in group A.
The cumulative patency rate according to type of AVF
was similar in the two groups, although there was a slightly
better outcome of brachiocephalic AVF in group B, which
was not statistically significant. Vascular access performed
with a prosthetic graft had a higher cumulative patency rate
in group A (P  .05; Table V). The creation of brachioce-
phalic AVFs in the elderly was more successful in our series,
showing higher and statistically significant primary (P 
.001) and cumulative patency (P  .03) rates compared
with radiocephalic AVFs.
As expected, the number of patients who had died
after AVF formation was higher in group A (109 vs 24;
P  .002). The rate of patients who died with a func-
tioning AVF was similar in the two groups (56% vs 54%).
Furthermore, the number of days that the conduit con-
tinued to function for was similar in the two groups (516
vs 511 days), as indicated by the Kaplan-Meier curves
(Fig).
DISCUSSION
In this study we present one of the largest series
evaluating the outcome of conduit creations in elderly
patients. These results support the principle that conduit
formation is as worthwhile in elderly patients as it is in
younger patients receiving HD. A substantial number of
studies have been published in the recent past analyzing
the outcome of conduit formation in general, but not
many have focused on the growing population of elderly
requiring HD. Initially, the creation of conduits in the
elderly did not have encouraging results, but in the
Table IV. Procedure to treat arteriovenous fistula failure
Procedure Group A (65) Group B (65) P
Fistuloplasty 26 16 .09
Thrombectomy 15 8 .34
Surgical revisiona 11 7 .27
Total 52 31 .01
aIncludes repeat anastomosis, transposition/superficialization, and ligation
of tributaries.
Table V. Cumulative patency by type of arteriovenous
fistula (AVF)
Type of AVF
Group A (65) Group B (65)
Pa(%) (%)
Radiocephalic 62 68 .6
Brachiocephalic 76 88 .09
BB vein transposition 80 83 .8
PTFE 94 69 .05
BB, Brachiobasilic vein transposition; PTFE, polytetrafluoroethylene
aValues of P  .05 are not significant.following years, an increasing number of series have ftrengthened opinion in favor of conduit formation in
he elderly.6,8-14
The patients included in our study reflect the popula-
ion encountered in the catchment area of our institution,
esembling a higher proportion of elderly white patients
nd a growing younger population from ethnic minorities.
his social background may help to interpret the ethnic
ifferences in the two groups we present and also the
ifferences in diabetes and history of HD.
The liberal use of inclusion and exclusion criteria in
any published series makes it rather complicated to
efine an acceptable cumulative patency rate. Our results
re comparable to those already published,4,10,15-19 con-
idering also that we included the conduits that failed to
ature in the study analysis (21% of all causes of failure in
roup A). Also in our series, the patency rates were
igher than the weighted mean patency rates of a recent
eta-analysis.20
In our practice, we favor radiocephalic AVF as first
hoice also in the elderly if judged appropriate; the
atency rate of radiocephalic AVF in our series was
imilar in the two groups, and our cumulative patency
CP) rate of 65% at 12 months in the elderly was better
han that published in a recent meta-analysis, which
howed a CP rate of 54% at 12 months.20,21 The strategy
e use in the elderly is not aimed at attempting a distal
VF at all costs, and we try to offer patients the most
otentially successful conduit first.
The principle of saving more proximal veins for later
se may not always be rewarding in the elderly. The
uality and the size of the veins in the forearm are more
ommonly inadequate for the creation of a distal AVF.
lso, the failure of a distal AVF may expose the elderly
atient to the need for percutaneous cannulation of large
essels for emergency HD and may instigate a spiral of
ong hospital admission potentially associated with an
ncreased risk of lethal complications. Moreover, these
atients have a shorter life expectancy, as documented by
ublished series on survival of the elderly after starting
D showing that 50% of patients aged 75 died 2
ears after starting HD, with a mean survival of 31
onths.22 A different series found that the median sur-
ival of octogenarians undergoing HD was 28 months.23
Brachiobasilic vein transposition showed good results
ith high patency rates of 80% in group A and 83% in group
and no difference between the two groups. Similar results
ere found also in other series.20,24,25
Fewer attempts were made to salvage conduits in the
lderly group. This can be explained by the higher
ncidence of conduits that failed to mature, and in our
eries, this particular subgroup proved to be particularly
efractory to any attempted procedure to rescue a pri-
ary nonfunctioning AVF. This may suggest that in the
ase of primary nonfunctioning AVF in the elderly, it
ay be acceptable to create a new AVF rather than to
ttempt to rescue the AVF, particularly in an AVF that
ailed to mature.
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access in the 65 age group was an achievable target
with high patency rates; the exclusion of the conduits
that failed to mature from our series would raise the CP
rate to 78%. However, we believe that this specific com-
plication should always be included in the analysis, par-
ticularly in the elderly, being more commonly encoun-
tered in this group of patients.
Although we do not use routine radiologic assessment
of venous anatomy, we believe that the incidence of failure
to mature in the elderly group should encourage the more
frequent use of duplex ultrasound assessment of elderly
patients to identify potential anatomic anomalies such as
stenosis or multiple branches.
Presently, there are no specific guidelines for conduit
creation in the elderly. However, the aim should be to
create a conduit with the highest chance of success first,
independently of its anatomic location.
Patency rates may not be the only outcome measure
for success26 of conduit creation in the elderly. Impor-
tant parameters such as life expectancy, cost, patient
preference, number of revisions needed, and length of
time for successful HD should be analyzed in future
studies to clarify the best options for a dramatically
Fig. Kaplan-Meier curves show the survival of all condui
three lines depicted for age65 years (red), with the low
primary patency; and the highest line, cumulative patenc
curve.growing elderly population.ONCLUSIONS
Excellent patency rates can be achieved after conduit
ormation in the elderly. Preoperative ultrasound scanning
ay be valuable to increase maturation rates. Attempts at
alvaging conduits in the elderly may be less worthwhile
han in younger patients.
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